Monday, June 15, 2026

Proton Therapy for Liver Cancer: Revolutionary Results from Samsung Medical Center

Samsung Medical Center's proton therapy shows high effectiveness for liver cancer, offering hope for patients unsuitable for standard treatments.

SK Hynix’s ADR Listing: Will It Outperform Micron in the Semiconductor Race?

SK Hynix's U.S. listing plans may shift investor focus from Micron, which has seen a significant stock decline amidst profit-taking.

Did North Korea Really Want to Ditch Its Nukes? Insights from Historic Talks

North Korea's positive response on disarming nuclear and chemical weapons is confirmed through inter-Korean meeting records.

Tag: Jongkundang Bio

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.